Questions?arveonix@protonmail.com•Telegram @arveonix

Last updated:

ARVEONIX BPC-157 10mg research product box and vial
Tissue research · SKU BC10

BPC-157 10mg

$60.00 AUD
In stock
Free shipping Australia-wideOrders over $150

BPC-157 is a synthetic pentadecapeptide studied in preclinical tissue, gastrointestinal, vascular and inflammatory-signalling models.

ProductBPC-157 10mg
SKUBC10
CategoryTissue research
Listed price$60.00 AUD
AvailabilityIn stock
Confirm current availability when making an enquiry.

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide widely discussed in preclinical research. Laboratory studies have explored its effects across tissue, gastrointestinal, vascular and inflammatory-signalling models.

The existing research base is heavily preclinical, so findings from cell and animal studies should not be presented as established clinical outcomes. Product pages are best used to describe the peptide's identity, research themes and experimental context.

Research category

Tissue research

ARVEONIX format

BPC-157 10mg · SKU BC10

Primary research context

Preclinical tissue and signalling research

Catalogue status

In stock · $60.00 AUD

Preclinical tissue and signalling research.

BPC-157 has been investigated across a broad range of biological models rather than being defined by one established receptor target. Research themes include vascular signalling, gastrointestinal models, inflammatory pathways and tissue responses.

Because proposed mechanisms vary between studies, careful interpretation requires attention to model type, experimental endpoint and whether findings have been independently replicated.

Common research themes.

Tissue models

Preclinical studies involving tissue response and repair-associated signalling.

Gastrointestinal research

Experimental models involving gastrointestinal tissue and barrier biology.

Vascular signalling

Research into endothelial and vascular-related pathways.

Inflammatory pathways

Study of signalling associated with inflammatory responses in preclinical models.

Research considerations.

Research findings should always be interpreted within the experimental system in which they were produced. Cell, receptor, tissue, animal and human studies can answer different questions, and results from one model should not automatically be treated as established outcomes in another.

ARVEONIX product pages therefore focus on molecule identity, pathway biology and published research themes rather than presenting experimental observations as guaranteed effects. The information here is not a dosing, treatment or individual-use recommendation.

BPC-157 FAQs.

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide used in preclinical research.

What does BPC-157 stand for?

The name is commonly expanded as Body Protection Compound-157 in research discussions.

Is the research mainly clinical?

No. Much of the published research commonly cited for BPC-157 is preclinical.

What areas are studied?

Tissue biology, gastrointestinal models, vascular signalling and inflammatory pathways.

What strength is this product?

This ARVEONIX product is BPC-157 10mg under SKU BC10.

Is BPC-157 the same as TB-500?

No. They are separate peptides with different research histories.

Does this page claim therapeutic efficacy?

No. It describes research context only.